Kristen Pierce - Oct 1, 2024 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chief Development Officer
Signature
/s/ Chris Erhlich, Attorney-in-Fact
Stock symbol
CERO
Transactions as of
Oct 1, 2024
Transactions value $
$0
Form type
4
Date filed
10/2/2024, 07:02 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +200K $0.00 200K Oct 1, 2024 Common Stock 200K $0.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in twenty-four (24) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.